Digital surgery provider Asensus Surgical, Inc. (ASXC) entered into a definitive merger agreement on June 7, 2024, with KARL STORZ Endoscopy-America, Inc., for about $93.45 million in cash.
Under the terms of the agreement, KARL STORZ, a wholly owned direct subsidiary of German medical device company KARL STORZ SE, will acquire all of the outstanding shares of Asensus Surgical for $0.35 per share in cash, representing a premium of 52.17% from the stock’s last close.